Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Outcome of metastatic breast cancer in selected women with or without deleterious BRCA mutations.

Clinical & experimental metastasis - 1 Jun 2013

Bayraktar S, Gutierrez-Barrera A M, Lin H, Elsayegh N, Tasbas T, Litton J K, Ibrahim N K, Morrow P K, Green M, Valero V, Booser D J, Hortobagyi G N, Arun B K

Abstract excerpt

The aim of this study was to compare the time-to progression and overall survival (OS) in patients with metastatic breast cancer (MBC) with and without deleterious BRCA1/2 mutations. 195 women with MBC who were referred for BRCA genetic testing between 1997 and 2011 were included in the study. Logistic regression models and Cox proportional hazards models were fit to determine the associations between clinical...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Neoplasm Metastasis
Share to Breast Neoplasms

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to BRCA1 gene

Share to BRCA2 gene

Share to Genes, BRCA1

Share to Genes, BRCA2

Share to Genetic Predisposition to Disease

Share to Outcome Assessment, Health Care

Source

Open in PubMed Open full text

Identifiers

PMID: 23370825
DOI: 10.1007/s10585-013-9567-8
PMCID: PMC3857726

Genes

BRCA1
BRCA2

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Outcome of metastatic breast cancer in selected women with or without deleterious BRCA mutations.PMID 23370825Read ↗

Survival outcomes of metastatic breast cancer patients by germline BRCA1/2 status in a large multicenter real‐world databaseSemantic proximity Read ↗

Outcome of triple-negative breast cancer in patients with or without deleterious BRCA mutations.Semantic proximity Read ↗

Risk of metastasis in BRCA2 carriers diagnosed with triple-negative breast cancer.Semantic proximity Read ↗

Association between BRCA mutational status and survival in patients with breast cancer: a systematic review and meta-analysis.Semantic proximity Read ↗

BRCA1 mutation in breast cancer patients: Analysis of prognostic factors and survivalSemantic proximity Read ↗

Incidence of contralateral and ipsilateral breast cancers and prognosis in BRCA1/2 pathogenic variant carriers based on the Japanese HBOC Consortium registration.Semantic proximity Read ↗

Long-term oncologic outcomes of unselected triple-negative breast cancer patients according to BRCA1/2 mutationsSemantic proximity Read ↗

BRCA1 Mutations Associated With Increased Risk of Brain Metastases in Breast Cancer: A 1: 2 Matched-pair Analysis.Semantic proximity Read ↗

Clinical outcome of breast cancer in carriers of BRCA1 and BRCA2 mutations according to molecular subtypesSemantic proximity Read ↗

Clinical outcome of triple negative breast cancer in BRCA1 mutation carriers and noncarriers.Semantic proximity Read ↗

Highly favorable outcome in BRCA-mutated metastatic breast cancer patients receiving high-dose chemotherapy and autologous hematopoietic stem cell transplantation.Semantic proximity Read ↗

Outcome of triple negative breast cancer: comparison of sporadic and BRCA1-associated cancers.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.